Kiran Mazumdar-Shaw On Claire Mazumdar & Biocon’s Future

Biocon Founder Kiran Mazumdar-Shaw joins Business Today TV for an exclusive conversation on Biocon’s next phase of growth, leadership transition and the global biosimilars opportunity. As Claire Mazumdar emerges as the named successor, Kiran Mazumdar-Shaw shares the key factors behind the transition and her long-term vision for the company. The discussion also dives deep into Biocon’s biosimilars business, the expanding GLP-1 and obesity drug opportunity, U.S. market dynamics, margin pressures, and the company’s FY27 roadmap. With Biocon entering a new era focused on execution, innovation and global scale, this conversation captures the future strategy of one of India’s biggest biotech companies. Watch the full interview only on Business Today TV.